Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2007, Vol. 12 ›› Issue (11): 1250-1254.
Previous Articles Next Articles
WANG Gui-ping1,2, LIU Xin-yan3, ZHU Liu3, YU Qing-sheng3
Received:2007-08-22
Revised:2007-10-29
Published:2020-11-04
CLC Number:
WANG Gui-ping, LIU Xin-yan, ZHU Liu, YU Qing-sheng. Immunoreactivity and neutralization against king cobra venom of antiking cobra venom IgY[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2007, 12(11): 1250-1254.
Add to citation manager EndNote|Ris|BibTeX
URL: https://manu41.magtech.com.cn/Jweb_clyl/EN/
https://manu41.magtech.com.cn/Jweb_clyl/EN/Y2007/V12/I11/1250
| 1 覃公平.中国毒蛇概述[A]. 见:覃公平, 主编.中国毒蛇学[M]. 第2 版.南宁:广西科学技术出版社, 1998: 1-8. 2 余清声, 黄劭, 朱柳, 等.眼镜王蛇伤抗蛇毒血清治疗的实验研究[J]. 中国危重危急救医学, 2000; 12:76-78. 3 Sarker SA, Casswall TH, Juneja LR, et al.Randomized,placebo-controlled, clinical trial of hyperimmunized chicken egg yolk immunoglobulin in children with rotavirus diarrhea[J]. J Pediatr Gastroenterol Nutr, 2001;32: 19-25. 4 Jintaridth P, Srisomsap C, Vichittumaros KE, et al.Chicken egg yolk antibodies specific for the gamma chain of human hemoglobin for diagnosis of thalassemia[J]. Int J Hematol,2006; 83:408-414. 5 Trampel DW, Zhou EM, Yoon KJ, et al.Detection of antibodies in serum and egg yolk following infection of chickens with an H6N2 avian influenza virus[J]. J Vet Diagn Invest,2006;18: 437-442. 6 Maya DC, Vasantha BM, Krishnan LK, et al.Development of viper-venom antibodies in chicken egg yolk and assay of their antigen binding capacity[J]. Toxicon, 2002;40: 857-861. 7 Paul K, Manjula J, Deepa EP, et al.Anti-Echis carinatus venom antibodies from chicken egg yolk: Isolation, purification and neutralization efficacy[J]. Toxicon, 2007; 50:893-900. 8 刘四红, 孔天翰.抗眼镜蛇毒鸡卵黄抗体的制备、纯化和保护性实验研究[J]. 中国病理生理杂志, 2006;22:2453-2457. 9 王桂平, 余清声, 覃媛, 等.抗眼镜王蛇毒鸡卵黄抗体的制备[J]. 中国药理学通报, 2004; 20:1426-1428. 10 薛海燕, 李红心, 宋宏新.抗大肠杆菌O157 鸡卵黄抗体的酶联免疫吸附试验[J]. 西北农林科技大学学报(自然科学), 2006;34: 51-54. |
| [1] | CAO Xuefen, LENG Yufang, HAN Xiaoxia, HOU Xiaoyu, LYU Xingjiao, Janvier NIBARUTA. Tetramethylpyrazine protected against intestinal ischemia-reperfusion injury induced pyroptosis by inhibiting NLRP3 inflammasome activation [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1201-1208. |
| [2] | WANG Jian, SUN Yongdong, ZHOU Xingwei, LIU Lei, CHEN Long, TONG Xingke, ZHU Jiali. Baicalein promotes laryngeal cancer cell death and inhibits invasion via miR-125b-5p/IRF4 axis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1209-1218. |
| [3] | ZHU Ruifang, GUO Dongkai, ZHI Hui, JIANG Yiguo, ZHANG Yueling, QIAN Xiaoping, JI Shiliang. Exploring the mechanism of elemene synergistic bortezomib against multiple myeloma by ROS-NF-κB-p38MAPK pathway [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1219-1226. |
| [4] | LI Fei, DING Huiqin, CHEN Mengjing. Isonlosinine induces autophagy of PC9 cells by ERK signaling pathway in lung cancer [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1235-1240. |
| [5] | SHI Dandan, SUN Yiyao, CHEN Xiaoqi, YANG Fangming, ZHANG Chuanlei, WANG Xinting, YUAN Changwei, CHEN Xinju. Curative effect of fuzheng xiaoliu granules in the treatment of primary liver cancer and analysis of serum metabolomics [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1247-1262. |
| [6] | CHEN Yulin, JIANG Hugang, WANG Xinqiang, LIU Kai, LI Yingdong, AN Tao, ZHAO Xinke. Effects and mechanism of Ginseng Yixin granules (QSYXG) for heart failure with preserved ejection fraction based on the network pharmacology and molecular docking strategy [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1081-1092. |
| [7] | WANG Xiu, JI Qilin, PEI Wenjun, ZENG Ying. 3-bromopyruvate cholesterol ester enhances the sensitivity of breast cancer cells to tamoxifen [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1093-1100. |
| [8] | HENG Bingbing, YANG Danfeng, DAI Shuyang, SHANGGUAN Wangning. Propofol relieves the subcutaneous chloroquine-induced pruritus in rats via TRPV1 and CB1 receptors of spinal cord [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1101-1108. |
| [9] | LIAO Mengling, WANG Yan, LUO Jing, WANG Nuoyan, HUA Ling, ZHANG Yu, DENG Fei, YUAN Yue, ZHOU Jun, ZHOU Hong. Molecular mechanism of artesunate attenuates the release of proinflammatory cytokines from macrophages [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 969-978. |
| [10] | YOU Rongli, HUANG Yurong, MAORui, HAI Lina, WANG Yingli, WANG Yan. Mechanism of compound kushen injection in the treatment of lung cancer based on serum metabolomics and network pharmacology [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 988-999. |
| [11] | WANG Ruyue, XIE Fei, WANG Xin, LI Hongyu. Therapeutic effect of lienal polypeptide injection on bone marrow suppression and immunodeficiency in KM mice following chemotherapy [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 1000-1007. |
| [12] | MAO Jun, RONG Yu, LI Yangen, XIONG Dengxi, ZHAO Peng, ZHA Zhengjiang. Effect and safety of flurbiprofen axetil in the analgesic treatment of patients with craniocerebral injury [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 1056-1060. |
| [13] | MA Xiankang, YANG Lixia, CUI Yangyang, MI Denghai. Angelica polysaccharides improve hepatic endoplasmic reticulum stress by inhibiting the expression of GRP78, p-PERK and p-Eif2α in diabetic KK-Ay mice [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(8): 926-936. |
| [14] | WANG Kun, XU Peipei, ZHOU Lanlan, LU Sheng. Mechanism of neuroprotective effect of ginsenoside Rg1 regulating Epac1/Rap1 signaling pathway in rats with ischemic stroke [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 721-727. |
| [15] | LI Shixu, LI Linyun, WANG Xin, LI Ke, BIAN Hua. Effects of Ginkgo biloba extract on renal injury in rats with experimental renal failure through miR-145/FOXO1 axis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 728-735. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
